Differentially imprinted innate immunity by mucosal boost vaccination determines antituberculosis immune protective outcomes, independent of T-cell immunity. (Q43514266)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Differentially imprinted innate immunity by mucosal boost vaccination determines antituberculosis immune protective outcomes, independent of T-cell immunity.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23131783%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Differentially imprinted innate immunity by mucosal boost vaccination determines antituberculosis immune protective outcomes, independent of T-cell immunity (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23131783%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23131783%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

author name string

M Jeyanathan

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23131783%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

D Damjanovic

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23131783%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

C R Shaler

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23131783%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

M Wortzman

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23131783%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

C Yin

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23131783%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

A Zganiacz

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23131783%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

B D Lichty

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23131783%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Z Xing

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23131783%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

publication date

7 November 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23131783%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Mucosal Immunology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23131783%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23131783%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23131783%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

612-625

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23131783%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Strategies and implications for prime-boost vaccination to generate memory CD8 T cells.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.103

21 January 2018

Jump-starting the immune system: prime-boosting comes of age.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.103

21 January 2018

Viruses as vaccine vectors for infectious diseases and cancer

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.103

21 January 2018

Viral vectors as vaccine platforms: deployment in sight

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.103

21 January 2018

Recent advances in the development of adenovirus- and poxvirus-vectored tuberculosis vaccines.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.103

21 January 2018

Heterologous prime-boost vaccinations for poverty-related diseases: advantages and future prospects

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.103

21 January 2018

Prime-boost immunization with poxvirus or adenovirus vectors as a strategy to develop a protective vaccine for HIV-1.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.103

21 January 2018

Mucosal immunity and vaccines

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.103

21 January 2018

Genetic heterologous prime-boost vaccination strategies for improved systemic and mucosal immunity

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.103

21 January 2018

What role does the route of immunization play in the generation of protective immunity against mucosal pathogens?

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.103

21 January 2018

Mucosal vaccination overcomes the barrier to recombinant vaccinia immunization caused by preexisting poxvirus immunity

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.103

21 January 2018

Nasal delivery of an adenovirus-based vaccine bypasses pre-existing immunity to the vaccine carrier and improves the immune response in mice

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.103

21 January 2018

T cells in mycobacterial infection and disease

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.103

21 January 2018

T-cell quality in memory and protection: implications for vaccine design

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.103

21 January 2018

Initiation and regulation of T-cell responses in tuberculosis

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.103

21 January 2018

Tuberculosis vaccine research: the impact of immunology

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.103

21 January 2018

Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.103

21 January 2018

First in humans: a new molecularly defined vaccine shows excellent safety and strong induction of long-lived Mycobacterium tuberculosis-specific Th1-cell like responses

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.103

21 January 2018

Intranasal Poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte/macrophage population

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.103

21 January 2018

Preexisting helminth infection induces inhibition of innate pulmonary anti-tuberculosis defense by engaging the IL-4 receptor pathway

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.103

21 January 2018

Understanding delayed T-cell priming, lung recruitment, and airway luminal T-cell responses in host defense against pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.103

21 January 2018

TNF-alpha is a critical negative regulator of type 1 immune activation during intracellular bacterial infection

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.103

21 January 2018

Mucosal vaccines: the promise and the challenge

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.103

21 January 2018

Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.103

21 January 2018

Comparative Immunogenicity in Rhesus Monkeys of DNA Plasmid, Recombinant Vaccinia Virus, and Replication-Defective Adenovirus Vectors Expressing a Human Immunodeficiency Virus Type 1 gag Gene

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.103

21 January 2018

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.103

21 January 2018

Mechanisms of mucosal and parenteral tuberculosis vaccinations: adenoviral-based mucosal immunization preferentially elicits sustained accumulation of immune protective CD4 and CD8 T cells within the airway lumen

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.103

21 January 2018

Heterologous boosting of recombinant adenoviral prime immunization with a novel vesicular stomatitis virus-vectored tuberculosis vaccine

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.103

21 January 2018

Fatal Mycobacterium tuberculosis infection despite adaptive immune response in the absence of MyD88.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.103

21 January 2018

Role of innate cytokines in mycobacterial infection.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.103

21 January 2018

Macrophages are a significant source of type 1 cytokines during mycobacterial infection

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.103

21 January 2018

The role of IL-10 in immune regulation during M. tuberculosis infection

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.103

21 January 2018

Interferon-alpha/beta inhibition of interleukin 12 and interferon-gamma production in vitro and endogenously during viral infection

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.103

21 January 2018

Induction of IFN-alphabeta enables Listeria monocytogenes to suppress macrophage activation by IFN-gamma

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.103

21 January 2018

Use of recombinant virus-vectored tuberculosis vaccines for respiratory mucosal immunization

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.103

21 January 2018

Progression of pulmonary tuberculosis and efficiency of bacillus Calmette-Guérin vaccination are genetically controlled via a common sst1-mediated mechanism of innate immunity.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.103

21 January 2018

A comparison of IFNgamma detection methods used in tuberculosis vaccine trials

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.103

21 January 2018

Respiratory infections: do we ever recover?

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.103

21 January 2018

Innate and adaptive immune correlates of vaccine and adjuvant-induced control of mucosal transmission of SIV in macaques

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.103

21 January 2018

Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.103

21 January 2018

Macrophages play a dual role during pulmonary tuberculosis in mice

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.103

21 January 2018

Versatility in NK cell memory

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.103

21 January 2018

Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha /beta

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.103

21 January 2018

Hypervirulent M. tuberculosis W/Beijing strains upregulate type I IFNs and increase expression of negative regulators of the Jak-Stat pathway

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.103

21 January 2018

Two roads diverged: interferon alpha/beta- and interleukin 12-mediated pathways in promoting T cell interferon gamma responses during viral infection

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.103

21 January 2018

Mucosal luminal manipulation of T cell geography switches on protective efficacy by otherwise ineffective parenteral genetic immunization

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.103

21 January 2018

Intranasal boosting with an adenovirus-vectored vaccine markedly enhances protection by parenteral Mycobacterium bovis BCG immunization against pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.103

21 January 2018

CD11c+ antigen presenting cells from the alveolar space, lung parenchyma and spleen differ in their phenotype and capabilities to activate naïve and antigen-primed T cells

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.103

21 January 2018

Adenoviral vectors for mucosal vaccination against infectious diseases.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.103

21 January 2018

Airway luminal T cells: a newcomer on the stage of TB vaccination strategies

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.103

7 January 2021

based on heuristic

inferred from DOI database lookup

Pulmonary mucosal dendritic cells in T-cell activation: implications for TB therapy

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.103

7 January 2021

based on heuristic

inferred from DOI database lookup

Type I interferons and IL-12: convergence and cross-regulation among mediators of cellular immunity

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.103

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43514266&oldid=2206094549"